These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 32037222
21. Novel platform for engineering stable and effective vaccines against botulinum neurotoxins A, B and E. Liu Y, Liu X, Chen W, Yu Y, Meng J, Wang J. Front Immunol; 2024; 15():1469919. PubMed ID: 39315101 [Abstract] [Full Text] [Related]
22. Chronic botulism in a Saxony dairy farm: sources, predisposing factors, development of the disease and treatment possibilities. Krüger M, Neuhaus J, Herrenthey AG, Gökce MM, Schrödl W, Shehata AA. Anaerobe; 2014 Aug; 28():220-5. PubMed ID: 24997242 [Abstract] [Full Text] [Related]
23. Intradermal immunization with botulinum neurotoxin serotype E DNA vaccine induces humoral and cellular immunity and protects against lethal toxin challenge. Kim NY, Ahn HB, Yu CH, Song DH, Hur GH, Shin YK, Shin S. Hum Vaccin Immunother; 2019 Aug; 15(2):412-419. PubMed ID: 30235058 [Abstract] [Full Text] [Related]
24. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain. Rani S, Ponmariappan S, Sharma A, Kamboj DV, Jain AK. Protein Pept Lett; 2017 Aug; 24(6):495-502. PubMed ID: 28260503 [Abstract] [Full Text] [Related]
25. Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen. Gao YL, Gao S, Kang L, Nie C, Wang JL. Hum Vaccin; 2010 Jun; 6(6):462-6. PubMed ID: 20519939 [Abstract] [Full Text] [Related]
26. Pentavalent replicon vaccines against botulinum neurotoxins and tetanus toxin using DNA-based Semliki Forest virus replicon vectors. Yu YZ, Liu S, Ma Y, Gong ZW, Wang S, Sun ZW. Hum Vaccin Immunother; 2014 Jun; 10(7):1874-9. PubMed ID: 25424795 [Abstract] [Full Text] [Related]
27. Subunit vaccine against the seven serotypes of botulism. Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT. Infect Immun; 2008 Mar; 76(3):1314-8. PubMed ID: 18070903 [Abstract] [Full Text] [Related]
28. Protective effect of botulinum C/D mosaic toxoid against avian botulism. Takeda M, Kasai H, Torii Y, Mukamoto M, Kohda T, Tsukamoto K, Kozaki S. J Vet Med Sci; 2006 Apr; 68(4):325-30. PubMed ID: 16679722 [Abstract] [Full Text] [Related]
29. Recombinant Botulinum Toxoids: A Practical Guide for Production. Moreira GMSG, Moreira C, da Cunha CEP, Mendonça M, Conceição FR. Methods Mol Biol; 2016 Apr; 1404():621-632. PubMed ID: 27076326 [Abstract] [Full Text] [Related]
30. Potent tetravalent replicon vaccines against botulinum neurotoxins using DNA-based Semliki Forest virus replicon vectors. Yu YZ, Guo JP, An HJ, Zhang SM, Wang S, Yu WY, Sun ZW. Vaccine; 2013 May 07; 31(20):2427-32. PubMed ID: 23583890 [Abstract] [Full Text] [Related]
37. Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A. Liu FJ, Shi DY, Mao YY, Xiong XH, Lu JS, Pang XB, Dong XJ, Yang ZX, Yu YZ. Vaccine; 2020 Mar 23; 38(14):2978-2983. PubMed ID: 32113807 [Abstract] [Full Text] [Related]